Statistical evaluation was by Student’sttest (KaleidaGraph, Synergy Software)

Statistical evaluation was by Student’sttest (KaleidaGraph, Synergy Software). == Animal Care == All animals were handled in accordance with the guidelines Rabbit Polyclonal to ARMX3 of the University of Kentucky Animal Care Committee. == RESULTS == == == == == == Yeast Two-hybrid Screens Show Human Cardiac PKA Interacts with Cardiac TnT == To identify signaling proteins that bind and post-translationally modify human cardiac troponin, we used a yeast two-hybrid approach to screen two separate adult human heart cDNA libraries (Clontech) with human cardiac TnT as bait. The yeast two-hybrid system (Y2H) is a sensitive eukaryotic assay widely and successfully used to detect novel interactions between proteins (22). filament proteins also reduced myofilament-bound PKA-type II. Using a cTn exchange procedure that substitutes the endogenous cTn complex with a recombinant cTn complex we show that PKA-type II is troponin-bound in the myofilament lattice. Displacement of PKA-cTnT complexes correlates with a significant decrease in myofibrillar PKA activity. Taken together, our data propose a novel role for cTnT as a dual-specificity sarcomeric AKAP. Keywords:Cardiac Muscle, Contractile Protein, Cyclic AMP (cAMP), Protein Kinase A (PKA), Protein Phosphorylation, Signal Transduction, AKAP, Cardiac Troponin, Ht31 Peptide, Human Heart Screening == Introduction == Activation of -adrenergic (-AR)2receptors in the heart is a major mechanism responsible for enhancing myocardial contractility. -AR receptor stimulation is quickly followed by a sharp rise in cyclic AMP levels evoking a plethora of physiological and biochemical reactions, such as positive chronotropic, inotropic or lusitropic effects (1,2). The effector arm of cAMP signaling is PKA, which translates the extracellular stimuli into timely and specific responses. PKA is a heterotetramer formed of two catalytic subunits kept in an inactive conformation by two regulatory subunits (either type I or II) (3). Another function of the regulatory (R) subunits is to facilitate tethering of the holoenzyme in the vicinity of relevant substrates thereby ensuring the fidelity of cAMP signaling (4,5). cAMP binds cooperatively to two sites termed A and B, located at the interface between a regulatory and catalytic subunit, releasing the catalytic subunit, which become catalytically active. Cardiomyocyte contraction-relaxation cycles are regulated by fluctuating intracellular Ca2+levels (6,7). Contraction is initiated by the opening of voltage-sensitive L-type Ca2+channels (LTCC) as a result of sarcolemmal depolarization. This causes a small influx of Ca2+that activates ryanodine receptors (RyR) promoting a massive release of Ca2+from the sarcoplasmic reticulum (SR) stores into the cytosol (8). The rise of intracellular Ca2+levels is sensed by troponin C (cTnC), which upon Ca2+binding undergoes a conformational change inducing dissociation of troponin Trimipramine I (cTnI) from actin. This movement is transmitted through cTnT to tropomyosin (Tm) exposing myosin binding sites on actin and promoting contraction. Relaxation occurs when Ca2+is pumped out of the cytosol by SERCA (sarcoplasmic reticulum calcium ATPase) or by Na+/Ca2+exchanger. PKA regulates the strength and frequency of contraction through phosphorylation of key proteins, such as LTCC, RYR, phospholamban, cTnI, myosin binding protein C (MyBP-C), and titin (9). Considering the extent and diversity of PKA targets within the cardiomyocyte, a Trimipramine tightly regulated and spatially segregated activity of the cAMP/PKA pathways is critical for the specificity of the response to the inciting stimulus (10,11). Both, speed and precision are achieved through: (i) targeting and pre-assembly of PKA signaling components in clusters, at discrete subcellular locations, through the help of protein kinase A anchoring proteins (12,13); and (ii) generation of local gradients of cAMP through spatially confined, phosphodiesterases (14). Phosphodiesterases, by Trimipramine degrading cAMP, regulate the amplitude, duration, and compartmentation of intracellular cyclic nucleotide signaling (10). The ingeniously assembled macromolecular complexes, containing AKAP, PKA, and other factors, confer efficient and specific transduction of cAMP signal. Growing data over the last decade have shed new light on the role of AKAP-PKA complexes bound to sarcoplasmic reticulum (regulating SERCA and RyR),t-tubules (regulating LTCC), and nuclear envelope (15). Despite the fact that cardiac myofilaments consist of >50% of the cellular volume (16) and that PKA-dependent phosphorylation of sarcomeric proteins cTnI, MyBP-C, and titin appear to be dominant in control of myofilament function by -AR stimulation (9), very little is known about the identity, composition, or function of AKAP-PKA complexes at the sarcomeres. Here we report the identification and characterization of a novel AKAP, Trimipramine cardiac TnT, which docks PKA at the thin filaments in proximity of its main sarcomeric substrates. == EXPERIMENTAL.